Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Uroboros Technologies LLC

DNA particles that spread out and grip cells

This article was originally published in Start Up

Executive Summary

Biotechnology companies almost always talk about the precise molecular targets their drugs are intended to hit. But targets per se aren’t seen as particularly important at Uroboros Technologies LLC, which aims to turn DNA nanoparticles into cancer therapeutics. Rather than pursue defined targets, the San Diego-based start-up just wants to find particles that bind to cancer cells and not to normal ones.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts